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Introduction
Neuroblastoma (NB) is an often fatal pediatric cancer that
arises from the precursor cells of the sympathetic nervous
system. 13-Cis retinoic acid is used to treat high-risk dis-
ease. A derivative, all-trans-retinoic acid (ATRA) causes
genome-wide demethylation in NB cells by up-regulating
miRNAs such as miR-152 and miR-26a/b which are pre-
dicted to target the methyltransferases DNMT1 and
DNMT3b, respectively. The purpose of this study was to
test whether ectopic over-expression of miR-26a/b, a
known tumor suppressor miRNA in several other cancer
types, led to reduced cell viability and DNMT3b expres-
sion in SK-N-BE NB cells. In addition, we also carried out
a methylated DNA immunoprecipitation to microarrays
following miR-152 over-expression in SK-N-BE cells in
order to assess whether the ectopic over expression of
miR-152 had any effects on genome-wide methylation.
Results
Results showed that reduced miR-26a/b expression corre-
lates to poor survival in patients with NB. We investigated
the possibility of epigenetic factors that could control
miR-26a/b expression in NB cells by treating the cells with
a DNA-demethylating agent (5’-Aza-2 deoxycytodine). We
did not observe any significant re-expression of miR-26a/b
after application of the drug. It was further shown that
ectopic over-expression of miR-26a causes a down-regula-
tion of DNMT3b mRNA. Cell viability assays carried out
following ectopic over-expression of miR-26a supported
its possible involvement in reducing cell growth levels 96
hours post-transfection. Using the SHEP-TET NB cell line
system, a MYCN induced repression of miR-26a/b in NB
was also ruled out. Genome-wide methylation analysis fol-
lowing over-expression of miR-152 revealed genes that
display overlapping methylation patterns as seen with
ATRA treatment alone, thus allowing the identification of
genes that are possibly controlled by miR-152 following
suppression of DNMT1.
Conclusions
Having ruled out DNA methylation and MYCN as signifi-
cant regulators of miR-26a/b expression during NB differ-
entiation, we propose that other transcription factors and/
or retinoic acid directly may regulate this microRNA. In
addition we have identified several genes that are epigen-
etically regulated through the action of miR-152 and
warrant further follow up to determine their importance
in NB differentiation.
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